- Home
-
Learn, develop, connect
8th Global QA Conference
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information -
Membership
Become part of RQA today
RQA membership is a great way to connect with your QA colleagues.
More information
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information - About us
News Archive
EMA Management Board highlights key outcomes from March 2026 meeting
18th March 2026The EMA Management Board has shared updates and key decisions from its March 2026 meeting.
EMA introduces new PRIME tools to accelerate medicine development
18th March 2026The European Medicines Agency has launched new tools to support faster development of promising medicines.
FDA releases draft guidance on alternatives to animal testing in drug development
18th March 2026The FDA has issued draft guidance promoting the use of non animal methods in drug development.
HRA launches follow up survey to assess improvements in study set up at sites
18th March 2026The Health Research Authority is seeking feedback to measure progress in improving study set up across the UK.
Patients to access new medicines up to six months earlier under MHRA and NICE collaboration
18th March 2026A new joint approval process aims to speed up patient access to innovative medicines in the UK.
New EMA Industry Highlights Quarterly Newsletter
17th March 2026The European Medicines Agency (EMA) Industry Highlights is a new quarterly newsletter for industry stakeholders providing updates on the latest regulatory and policy developments, with a focus on topics that directly impact industry and may require action.
EMA issues new guidance on conducting clinical trials during public health emergencies in the EU
12th March 2026The European Medicines Agency has released new guidance to support clinical trials during public health emergencies.
FDA launches new Adverse Event Look-up Tool
12th March 2026The US Food and Drug Administration has introduced a new tool to improve access to adverse event data.
FDA publishes CDER Guidance Agenda outlining planned drug guidance documents
12th March 2026The US Food and Drug Administration has published its latest CDER Guidance Agenda setting out potential guidance documents for drug regulation.
MHRA News: £14bn opportunity identified through medicine reclassification
12th March 2026New analysis highlights the economic and healthcare benefits of expanding access to medicines through reclassification.
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us